100% Core
Safe Lane
Core Breakdown:
89% Safe Lane
5% Roaming
5% Off Lane
0% Jungle
0% Mid Lane
Overview | Farm | |||||||
---|---|---|---|---|---|---|---|---|
Hero | Matches | Win % | KDA | LH | DN | GPM | XPM | |
Terrorblade | 3 | 33.33% | 4.33 | 475.33 | 13.33 | 666 | 610 | |
Templar Assassin | 2 | 100.00% | 5.56 | 392.00 | 20.00 | 646 | 655 | |
Lifestealer | 2 | 0.00% | 1.25 | 238.00 | 28.50 | 406 | 486 | |
Ursa | 2 | 0.00% | 1.18 | 270.50 | 9.00 | 429 | 481 | |
Monkey King | 1 | 100.00% | 4.00 | 767.00 | 24.00 | 742 | 682 | |
Axe | 1 | 100.00% | 0.00 | 0.00 | 0.00 | 134 | 54 | |
Troll Warlord | 1 | 100.00% | 25.00 | 214.00 | 16.00 | 682 | 683 | |
Bloodseeker | 1 | 100.00% | 18.00 | 346.00 | 16.00 | 663 | 707 | |
Faceless Void | 1 | 100.00% | 25.00 | 219.00 | 25.00 | 567 | 624 | |
Spectre | 1 | 0.00% | 1.40 | 290.00 | 19.00 | 444 | 540 | |
Juggernaut | 1 | 0.00% | 1.83 | 225.00 | 12.00 | 427 | 580 | |
Nature's Prophet | 1 | 0.00% | 1.57 | 193.00 | 10.00 | 443 | 493 | |
Wraith King | 1 | 0.00% | 1.00 | 349.00 | 10.00 | 507 | 490 | |
Slark | 1 | 0.00% | 1.00 | 163.00 | 8.00 | 420 | 639 |
League | Hero | Result | Team | Duration | KDA | Items |
---|---|---|---|---|---|---|
Lost Match | SE Asia | 30:18 | 0/5/5 | |||
Lost Match | Excandeso vs Unknown SE Asia | 27:53 | 2/7/9 | |||
Lost Match | SE Asia | 38:59 | 2/3/3 | |||
Lost Match | SE Asia | 38:57 | 6/6/5 | |||
Lost Match | SE Asia | 39:19 | 3/5/4 | |||
Won Match | SE Asia | 44:16 | 13/2/23 | |||
Won Match | SE Asia | 54:30 | 14/4/23 | |||
Lost Match | SE Asia | 45:16 | 3/7/5 | |||
Lost Match | SE Asia | 28:13 | 3/5/2 | |||
Lost Match | SE Asia | 38:53 | 3/6/3 |
Time Period | Matches | Win % | KDA |
---|---|---|---|
All Time | 19 | 42.11% | 3.48 |
League Tier | Matches | Win % | KDA |
Amateur | 19 | 42.11% | 3.48 |
Faction | Matches | Win % | KDA |
Radiant | 13 | 38.46% | 2.93 |
Dire | 6 | 50.00% | 4.91 |
League | Matches | |
---|---|---|
Epulze.com | 0-2 | |
FSL Dota 2 Ci…Wildcard | 2-3 | |
FSL Dota 2 Circuit 2…3 | 0-2 | |
FSL Dota 2 Circuit 2…2 | 4-2 | |
FSL Open II 2021 | 2-2 |